biotechdispatch.com.au valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Sitemap: http://biotechdispatch.com.au/sitemap.xml User-agent: * Disallow: /action/ Allow: | ||
Meta Tags
| Title | BiotechDispatch - |
| Description | BostonGene and Mater Research collaborate in new follicular lymphoma Explore the Site Latest News AusBiotech Events About Contact Subscribe Search Follow Us LinkedIn Twitter Instagram BiotechDispatch Menu May 07, 2023 Subsc |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 119.9.8.73 |
| Location | Australia |
Related Websites
| Site | Rank |
More to Explore
biotechdispatch.com.au Valuation
|
US$2,395,207
Last updated: 2023-05-07 18:57:17
biotechdispatch.com.au has Semrush global rank of 4,418,952. biotechdispatch.com.au has an estimated worth of US$ 2,395,207, based on its estimated Ads revenue. biotechdispatch.com.au receives approximately 276,370 unique visitors each day. Its web server is located in Australia, with IP address 119.9.8.73. According to SiteAdvisor, biotechdispatch.com.au is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,395,207 |
| Daily Ads Revenue | US$2,211 |
| Monthly Ads Revenue | US$66,329 |
| Yearly Ads Revenue | US$795,946 |
| Daily Unique Visitors | 18,425 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| biotechdispatch.com.au. | A | 10800 | IP: 119.9.8.73 |
| biotechdispatch.com.au. | NS | 3600 | NS Record: pdns13.domaincontrol.com. |
| biotechdispatch.com.au. | NS | 3600 | NS Record: pdns14.domaincontrol.com. |
| biotechdispatch.com.au. | MX | 3600 | MX Record: 0 biotechdispatch-com-au.mail.protection.outlook.com. |
| biotechdispatch.com.au. | TXT | 3600 | TXT Record: v=spf1 include:secureserver.net -all |
| biotechdispatch.com.au. | TXT | 3600 | TXT Record: NETORGFT7771701.onmicrosoft.com |
HtmlToTextCheckTime:2023-05-07 18:57:17
| Explore the Site Latest News AusBiotech Events About Contact Subscribe Search Follow Us LinkedIn Twitter Instagram BiotechDispatch Menu May 07, 2023 Subscribe Login Latest News AusBiotech Events About Contact Subscribe Search Sign In Login Forgot password? Latest News BostonGene and Mater Research collaborate in new follicular lymphoma study May 4, 2023 AusBiotech Opportunity to invest in Australian biotech companies May 4, 2023 Latest News Radiopharm Theranostics announces positive new publication for RAD301 platform May 4, 2023 Latest News Carina Biotech to present details of planned trial of CAR-T cell therapy candidate May 4, 2023 Cell therapy immuno-oncology company Carina Biotech has announced a poster presentation showcasing its planned Phase 1/2a clinical trial of its LGR5-targeted CAR-T cell therapy candidate CNA3103 in patients with metastatic colorectal cancer. Latest News Patent granted in India and Notice of Allowance Issued in Israel for CLTX Car Technology May 4, 2023 |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: Apache/2.4.29 (Ubuntu) Content-Type: text/html; charset=UTF-8 Strict-Transport-Security: max-age=31536000 Date: Thu, 28 Oct 2021 14:21:28 GMT Location: https://biotechdispatch.com.au/ Transfer-Encoding: chunked X-Content-Type-Options: nosniff Connection: Keep-Alive HTTP/2 200 server: Apache/2.4.29 (Ubuntu) content-type: text/html; charset=UTF-8 strict-transport-security: max-age=31536000 date: Thu, 28 Oct 2021 14:21:29 GMT x-content-type-options: nosniff set-cookie: d10497f02b62dee95b6da92ce6d86cc0_id=20243882; expires=Tue, 29-Nov-2022 14:21:29 GMT; Max-Age=34300800; path=/; domain=.biotechdispatch.com.au set-cookie: d10497f02b62dee95b6da92ce6d86cc0_hash=07bca27b4b31262bcc49f1f9a2b5117d; expires=Tue, 29-Nov-2022 14:21:29 GMT; Max-Age=34300800; path=/; domain=.biotechdispatch.com.au |